Nicotine therapeutic benefits: Difference between revisions
| Line 1,238: | Line 1,238: | ||
='''Parkinson Disease'''= | ='''Parkinson Disease'''= | ||
===2025: [https://pubmed.ncbi.nlm.nih.gov/40465192/ Integrative Network Pharmacology, Molecular Docking, and Dynamics Simulation Guided Discovery of Anethole, Carvacrol, Carnosol, Nicotine, and Paeonol as Potential Therapeutics for Parkinson's Disease]=== | |||
*"In conclusion, these findings suggest potential therapeutic mechanisms of the identified constituents in PD and may provide a basis for future preclinical and clinical studies to further explore their neuroprotective effects." | |||
**Citation: Tusar MTT, Munna MMR, Ahmed MH, Rahman MM, Fatema K, Islam KM, Ali MS. Integrative Network Pharmacology, Molecular Docking, and Dynamics Simulation Guided Discovery of Anethole, Carvacrol, Carnosol, Nicotine, and Paeonol as Potential Therapeutics for Parkinson's Disease. Cell Biochem Biophys. 2025 Jun 4. doi: 10.1007/s12013-025-01791-6. Epub ahead of print. PMID: 40465192. | |||
***The authors declare no competing interests. (No funding information provided on the version viewed at the link above.) | |||
===2024 [https://www.sciencedirect.com/science/article/abs/pii/S0967586824003849 The effect of a nicotine-rich diet with/without redistribution of dietary protein on motor indices in patients with Parkinson's disease: A randomized clinical trial]=== | ===2024 [https://www.sciencedirect.com/science/article/abs/pii/S0967586824003849 The effect of a nicotine-rich diet with/without redistribution of dietary protein on motor indices in patients with Parkinson's disease: A randomized clinical trial]=== | ||